Toward a durable anti-HIV gene therapy based on RNA interference
- PMID: 19796072
- PMCID: PMC7167650
- DOI: 10.1111/j.1749-6632.2009.04972.x
Toward a durable anti-HIV gene therapy based on RNA interference
Abstract
Basic research in the field of molecular biology led to the discovery of the mechanism of RNA interference (RNAi) in Caenorhabditis elegans in 1998. RNAi is now widely appreciated as an important gene control mechanism in mammals, and several RNAi-based gene-silencing applications have already been used in clinical trials. In this review I will discuss RNAi approaches to inhibit the pathogenic human immunodeficiency virus type 1 (HIV-1), which establishes a chronic infection that would most likely require a durable gene therapy approach. Viruses, such as HIV-1, are particularly difficult targets for RNAi attack because they mutate frequently, which allows viral escape by mutation of the RNAi target sequence. Combinatorial RNAi strategies are required to prevent viral escape.
Conflict of interest statement
The author declares no conflicts of interest.
Similar articles
-
Toward a durable treatment of HIV-1 infection using RNA interference.Prog Mol Biol Transl Sci. 2011;102:141-63. doi: 10.1016/B978-0-12-415795-8.00001-5. Prog Mol Biol Transl Sci. 2011. PMID: 21846571 Review.
-
Towards a durable RNAi gene therapy for HIV-AIDS.Expert Opin Biol Ther. 2009 Feb;9(2):161-70. doi: 10.1517/14712590802653619. Expert Opin Biol Ther. 2009. PMID: 19236246 Review.
-
RNAi as a treatment for HIV-1 infection.Biotechniques. 2006 Apr;Suppl:25-9. doi: 10.2144/000112167. Biotechniques. 2006. PMID: 16629384 Review.
-
Gene therapy strategies to block HIV-1 replication by RNA interference.Adv Exp Med Biol. 2015;848:71-95. doi: 10.1007/978-1-4939-2432-5_4. Adv Exp Med Biol. 2015. PMID: 25757616 Review.
-
RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.Antivir Chem Chemother. 2009;19(6):221-33. doi: 10.1177/095632020901900602. Antivir Chem Chemother. 2009. PMID: 19641231 Review.
Cited by
-
Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.Retrovirology. 2012 Feb 20;9:17. doi: 10.1186/1742-4690-9-17. Retrovirology. 2012. PMID: 22348230 Free PMC article.
-
Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.Mol Ther Nucleic Acids. 2019 Jun 7;16:452-462. doi: 10.1016/j.omtn.2019.04.001. Epub 2019 Apr 8. Mol Ther Nucleic Acids. 2019. PMID: 31048184 Free PMC article.
-
Silencing of HIV-1 by AgoshRNA molecules.Gene Ther. 2017 Aug;24(8):453-461. doi: 10.1038/gt.2017.44. Epub 2017 May 29. Gene Ther. 2017. PMID: 28553929
-
Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells.Mol Biol Rep. 2012 Apr;39(4):3675-81. doi: 10.1007/s11033-011-1142-2. Epub 2011 Jul 6. Mol Biol Rep. 2012. PMID: 21732059
-
Possible applications for replicating HIV 1 vectors.HIV Ther. 2010 May 1;4(3):361-369. doi: 10.2217/hiv.10.20. HIV Ther. 2010. PMID: 20582153 Free PMC article.
References
-
- Fire, A. , Xu S., Montgomery M.K., Kostas S.A., et al 1998. Potent and specific genetic interference by double‐stranded RNA in Caenorhabditis elegans. Nature 391: 806–811. - PubMed
-
- He, L. & Hannon G.J.. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5: 522–531. - PubMed
-
- Elbashir, S.M. , Harborth J., Lendeckel W., et al 2001. Duplexes of 21‐nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494–498. - PubMed
-
- Brummelkamp, T.R. , Bernards R. & Agami R.. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550–553. - PubMed
-
- Hammond, S.M. , Bernstein E., Beach D. & Hannon G.J.. 2000. An RNA‐directed nuclease mediates post‐transcriptional gene silencing in Drosophila cells. Nature 404: 293–296. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical